Biopharmaceutical Analysis & Statistics, September 2014

Talk to Clare

+1 339 368 6001

Publishers

All regions

You might be interested in: protein, biomedical, antibody, more »

1-40 of about 1 100 reports

Purchase Reports From Reputable Market Research Publishers

Global Markets for Bioengineered Protein Drugs

Global Markets for Bioengineered Protein Drugs

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report explores the present and future strategies within the bioengineered protein drugs market. It analyzes each market and its applications, regulatory environment, technologies involved, ...

  • Industries : Biopharmaceutical
  • Countries : World
Global Markets for Enzymes in Industrial Applications

Global Markets for Enzymes in Industrial Applications

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

Widespread research in the field of industrial enzymes has revealed the influence of enzyme technology in almost every sector of industrial activity, ranging from technical field to food, feed and healthcare ...

  • Industries : Biopharmaceutical
  • Countries : World
Biosimilars - Biosimilars on the cusp of a new era

Biosimilars - Biosimilars on the cusp of a new era

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

The biosimilars market is undergoing rapid change with developments such as the recent approvals of infliximab and trastuzumab heralding a new era. In order to keep up with the pace of change in the marketplace, ...

  • Industries : Biopharmaceutical
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States
PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

  • $ 2 995
  • Industry report
  • June 2014
  • by Global Data

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market Summary GlobalData's report, "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars ...

  • Industries : Biopharmaceutical
  • Countries : South Korea, India, World, China, United States, Japan, Asia, Europe
Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines

  • $ 2 500
  • Industry report
  • August 2014
  • by Kelly Scientific Publications

“PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines” by Kelly Scientific ...

  • Industries : Biopharmaceutical
  • Countries : India
Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

Growth Hormone Deficiency - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H2 2014', provides an overview of the Growth Hormone Deficiency's therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Research on China Monoclonal Antibody (McAB) Industry, 2014

Research on China Monoclonal Antibody (McAB) Industry, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Huidian Research

Please note: The report is Chinese version. It will provide the English version in two business days. Research on China Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth analysis on ...

  • Industries : Biopharmaceutical
  • Countries : China
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

  • $ 1 899
  • Industry report
  • August 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage ...

  • Industries : Biopharmaceutical
  • Countries : United States
Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Biopharmaceutical
TARIS BioMedical, Inc. - Product Pipeline Review - 2014

TARIS BioMedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

TARIS BioMedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘TARIS BioMedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TARIS BioMedical, Inc.'s ...

  • Industries : Biopharmaceutical
  • Countries : World
Boston Biomedical, Inc. - Product Pipeline Review - 2014

Boston Biomedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Boston Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Boston Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the Boston Biomedical, Inc.'s ...

  • Industries : Biopharmaceutical
  • Countries : World
Pfenex Inc. - Product Pipeline Review - 2014

Pfenex Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Pfenex Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development ...

  • Industries : Biopharmaceutical
  • Countries : World
Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Genervon ...

  • Industries : Biopharmaceutical
  • Countries : World
Bristol-Myers Squibb Company - Product Pipeline Review - 2014

Bristol-Myers Squibb Company - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Bristol-Myers Squibb Company - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bristol-Myers Squibb Company - Product Pipeline Review - 2014', provides an overview of the Bristol-Myers ...

  • Industries : Biopharmaceutical
  • Countries : World
Antibody Deals and Alliances of 2013

Antibody Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Antibody Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Biopharmaceutical
 Growth Hormone Deficiency-Pipeline Insights, 2014

Growth Hormone Deficiency-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Growth Hormone Deficiency-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Biopharmaceutical
Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“5-Lipoxygenase Activating Protein (FLAP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Biopharmaceutical
AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMP Activated Protein Kinase (AMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Amyloid Protein Blockers -Pipeline Insights, 2014

Amyloid Protein Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Amyloid Protein Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Anti-CD105 Antibody -Pipeline Insights, 2014

Anti-CD105 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD105 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
About 3 300 reports

Download Unlimited Documents from Trusted Public Sources

Adacel Technologies - Company Report, September 2014

  • Stock Summary
  • September 2014
    12 pages
  • Drug And Medica...  

    Biopharmaceutic...  

  • Australia  

View report >

Vaccine Market In The Us

September 2014

Vaccine Supply In Europe

September 2014

Antigen Market

September 2014

Vaccine Market

September 2014

29 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.